You are browsing the Radio-Canada website
Skip to main contentGo to footerNavigation help Start of main content
commentsAccess the comments section
Open in full screen mode
A bottle containing pills of the opiate OxyContin, produced by Purdue Pharma. (Archive photo)
Photo : Reuters / George Frey
Posted at 10:19 a.m. EDTUpdated at 10:39 a.m. EDT
The US Supreme Court on Thursday rejected the validity of a compensation agreement of some $6 billion in the opioid crisis on the grounds that it exempted the Sackler family, owner of the Purdue laboratory, from any future lawsuits from victims.
The Court ruled by a majority of five votes to four. The Department of Justice criticized this agreement, concluded in 2022 with the 50 American states, local communities and individual victims and validated by a federal appeals court, for protecting the Sackler family from all future prosecutions, including victims who did not consent.
More details to come
National Info Newsletter
News, analysis, reports: twice a day, receive the essential news.
